Codexis (CDXS)
(Real Time Quote from BATS)
$2.64 USD
+0.02 (0.76%)
Updated Sep 10, 2024 10:58 AM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Income Statements
Fiscal Year end for Codexis, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 70 | 139 | 105 | 69 | 68 |
Cost Of Goods | 13 | 38 | 22 | 14 | 16 |
Gross Profit | 57 | 101 | 83 | 55 | 53 |
Selling & Adminstrative & Depr. & Amort Expenses | 125 | 135 | 105 | 79 | 65 |
Income After Depreciation & Amortization | -68 | -35 | -23 | -24 | -13 |
Non-Operating Income | -8 | 2 | 2 | 0 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -76 | -33 | -21 | -24 | -12 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -76 | -34 | -21 | -24 | -12 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -76 | -34 | -21 | -24 | -12 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -58 | -25 | -17 | -19 | -8 |
Depreciation & Amortization (Cash Flow) | 10 | 10 | 6 | 5 | 5 |
Income After Depreciation & Amortization | -68 | -35 | -23 | -24 | -13 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 68.13 | 65.34 | 64.57 | 59.36 | 56.53 |
Diluted EPS Before Non-Recurring Items | -0.74 | -0.51 | -0.33 | -0.40 | -0.21 |
Diluted Net EPS (GAAP) | -1.12 | -0.51 | -0.33 | -0.40 | -0.21 |
Fiscal Year end for Codexis, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 7.98 | 17.07 | 26.56 | 9.28 | 21.32 |
Cost Of Goods | 3.46 | 4.86 | 2.86 | 2.25 | 3.18 |
Gross Profit | 4.52 | 12.22 | 23.70 | 7.03 | 18.15 |
SG&A, R&D, and Dept/Amort Expenses | 27.25 | 24.11 | 23.41 | 39.09 | 30.77 |
Income After SG&A, R&D, and Dept/Amort Expenses | -22.73 | -11.89 | 0.29 | -32.06 | -12.62 |
Non-Operating Income | -0.01 | 0.39 | -7.44 | -2.84 | 1.11 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -22.75 | -11.50 | -7.16 | -34.90 | -11.51 |
Income Taxes | 0.01 | 0.01 | 0.04 | 0.01 | 0.01 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -22.76 | -11.51 | -7.19 | -34.91 | -11.52 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -22.76 | -11.51 | -7.19 | -34.91 | -11.52 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 70.38 | 69.85 | 69.50 | 69.47 | 67.57 |
Diluted EPS Before Non-Recurring Items | -0.32 | -0.16 | 0.02 | -0.26 | -0.17 |
Diluted Net EPS (GAAP) | -0.32 | -0.16 | -0.11 | -0.50 | -0.17 |